Mode
Text Size
Log in / Sign up

FDA approved OxyContin (oxycodone) for Severe Pain in Adults and Pediatric PatientsFDA approved new opioid painkiller OxyContin for severe pain.

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider reserving OxyContin for patients with severe pain unresponsive to alternatives, using lowest effective dose for shortest duration.

The FDA has approved OxyContin (oxycodone extended-release tablets) for the management of severe and persistent pain that requires an opioid analgesic and cannot be adequately treated with alternative options, including immediate-release opioids. The indication covers adults and opioid-tolerant pediatric patients aged 11 years and older who already receive and tolerate a minimum daily opioid dose of at least 20 mg oral oxycodone or equivalent. OxyContin is not indicated for as-needed (prn) analgesia. The approval highlights the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration. Clinicians should reserve OxyContin for patients in whom alternative treatment options are ineffective, not tolerated, or otherwise inadequate. The drug must be prescribed only by healthcare professionals knowledgeable about extended-release opioids and risk mitigation.

Clinical Details (Mechanism · Dosing · Trial Data · Warnings)
Mechanism of Action

Oxycodone is an opioid agonist. The label does not provide specific mechanism details beyond its opioid agonist activity.

Indication & Patient Population

OxyContin is indicated for management of severe and persistent pain that requires an opioid analgesic and cannot be adequately treated with alternative options, including immediate-release opioids, in adults and opioid-tolerant pediatric patients 11 years and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent. Limitations include reserving use for patients with inadequate alternatives and not for as-needed analgesia.

Dosing & Administration

OxyContin should be prescribed only by healthcare professionals knowledgeable about extended-release/long-acting opioids and risk mitigation. The 60 mg and 80 mg tablets, a single dose greater than 40 mg, or a total daily dose greater than 80 mg are only for patients with established opioid tolerance. Opioid-tolerant patients are those taking, for one week or longer, at least 60 mg oral morphine per day, 25 mcg transdermal fentanyl per hour, 30 mg oral oxycodone per day, 8 mg oral hydromorphone per day, 25 mg oral oxymorphone per day, 60 mg oral hydrocodone per day, or an equianalgesic dose of another opioid. Use the lowest effective dosage for the shortest duration. Administer orally every 12 hours. Instruct patients to swallow tablets intact; do not cut, break, chew, crush, or dissolve. For adults not opioid-tolerant, initiate with 10 mg orally every 12 hours. For pediatric patients 11 years and older, use only in those already receiving and tolerating opioids for at least 5 consecutive days with a minimum of 20 mg per day of oxycodone or equivalent for at least two days immediately preceding dosing. In debilitated, opioid non-tolerant geriatric patients and patients with hepatic impairment, initiate at one third to one half the recommended starting dosage and titrate carefully.

Key Clinical Trial Data

Trial data not available in label.

Warnings & Contraindications

Risks include addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration. Respiratory depression can occur at any time, especially during initiation and dose increases. Discuss opioid overdose reversal agents with patients and caregivers. Do not rapidly reduce or abruptly discontinue in physically dependent patients. OxyContin 60 mg and 80 mg tablets, single doses >40 mg, or total daily doses >80 mg are only for opioid-tolerant patients.

Place in Therapy

OxyContin is reserved for patients with severe and persistent pain requiring an opioid analgesic when alternative treatments are ineffective, not tolerated, or otherwise inadequate. It is not for as-needed use. Use the lowest effective dose for the shortest duration.

The FDA has approved a new drug called OxyContin (oxycodone extended-release) for managing severe, persistent pain that requires daily, around-the-clock opioid treatment. This medication is for adults and children aged 11 and older who already take and tolerate a certain amount of opioids each day. It is not meant for pain that comes and goes or for use as needed.

OxyContin is a strong opioid, which means it carries serious risks, including addiction, abuse, misuse, overdose, and even death. These risks can happen at any dose or length of treatment. Because of these dangers, doctors should only prescribe OxyContin when other pain treatments have not worked or cannot be used.

This approval gives doctors another option for patients with severe pain that is not controlled by other medicines. However, it is not a first-choice treatment. Patients and their families should talk to their doctor about all the risks and benefits before starting this medicine. It is important to use OxyContin exactly as prescribed and to store it safely away from others.

What this means for you:
OxyContin is a strong opioid for severe pain when other treatments fail; talk to your doctor about risks.

Study Details

Study typeFda approval
PublishedApr 2010
View Original Abstract ↓
1 INDICATIONS AND USAGE OXYCONTIN is indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids, in: Adults; and Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.1) ] , reserve opioid analgesics, including OXYCONTIN, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. OXYCONTIN is not indicated as an as-needed (prn) analgesic. OXYCONTIN is an opioid agonist indicated for the management of severe and persistent pain that requires an opioid analgesic that cannot be adequately treated with alternative options, including immediate-release opioids in: Adults ( 1 ); and Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent. ( 1 ) Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including OXYCONTIN, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. ( 1 , 5.1 ) OXYCONTIN is not indicated as an as-needed (prn) analgesic. ( 1 )
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.